In a report released today, Alex Thompson CFA from Stifel Nicolaus maintained a Buy rating on Immunovant (IMVT – Research Report), with a price ...

In a report released today, Tore Svanberg from Stifel Nicolaus maintained a Buy rating on Ambarella (AMBA – Research Report), with a price ...

CONMED (NYSE:CNMD – Get Free Report) had its price target increased by research analysts at Stifel Nicolaus from $72.00 to $75.00 in a research note issued to investors on Thursday,Benzinga reports.

The reason is simple: our research has shown that we can outperform ... On February 5, David Grossman from Stifel Nicolaus maintained a “Buy” rating on the stock with a price target of $ ...

In addition, GH Research PLC has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 ordinary shares at the public offering price, less underwriting discounts and ...

Stifel Nicolaus’ target price would indicate a potential upside of 36.14% from the company’s current price. A number of other equities research analysts have also recently commented on the stock.

They are solving some of the current challenges in cybersecurity and imaging to protect people and organizations. Through research, RIT is making an impact. RIT is one of the top universities in the ...

The Emerson Fellowship fosters student participation in undergraduate research and experiential learning by offering a 10-week, full-time, paid summer undergraduate research experience at RIT. The ...

(RTTNews) - Stifel Financial Corp. (SF) revealed earnings for its fourth quarter that increased from last year and beat the Street estimates. The company's earnings totaled $234.69 million ...

Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe ...

The directive also suspended the grant review panels that determine which research projects receive funding. As a result of these disruptions, NIH staff has reported being unable to meet with ...

January 28, 2025 Chris O'Cull, analyst from investment company Stifel Nicolaus, reiterated Buy rating on Starbucks (NASDAQ:SBUX) today and increased the price target from $110 to $114. The market ...